IMA-402

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameIMA-402

Drug Alias NameIMA-402

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > T cell engagers

Mechanisms of ActionT lymphocytes stimulantsAnti-Melanoma antigen preferentially expressed in tumors

TargetsMelanoma antigen preferentially expressed in tumors

Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesNetherlandsGermany

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic Neoplasms

Inactive IndicationsNeoplasms

ATC CodeN/A